SCHEMBL30719869

SCHEMBL30719869

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.49
▸ GRIN3B O60391 1/20 0.49
▸ GRIN1 Q05586 1/20 0.49
▸ GRIN2A Q12879 1/20 0.49
▸ GRIN2B Q13224 1/20 0.49
▸ GRIN2C Q14957 1/20 0.49
▸ GRIN3A Q8TCU5 1/20 0.49
▸ F2 P00734 2/20 0.43
▸ SLC6A5 Q9Y345 1/20 0.42
▸ CPB2 Q96IY4 1/20 0.41
▸ FURIN P09958 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ NMT2 O60551 1/20 0.40
▸ NMT1 P30419 1/20 0.40
▸ SLC15A2 Q16348 1/20 0.40
▸ PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30661869 0.91 ENPEP (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30661870 0.90 ENPEP (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30719878 0.87 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9302786 0.86 GRIN2D (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9302800 0.86 GRIN2D (0.58) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30904474 0.85 GRIN2D (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29933967 0.84 GRIN2D (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31354608 0.84 ENPEP (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31575680 0.83 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29607845 0.82 BACE1 (0.51) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024003873-A1 SINGLE VARIABLE DOMAIN ANTIBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA INTREXON ACTOBIOTICS NV D/B/A PRECIGEN ACTOBIO (BE) 2024-01-04 — — WO claimed
WO-2024003873-A1 SINGLE VARIABLE DOMAIN ANTIBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA INTREXON ACTOBIOTICS NV D/B/A PRECIGEN ACTOBIO (BE) 2024-01-04 — — WO disclosed
Send feedback